PROSTATE cancerANDROGEN deprivation therapyTHERAPEUTICSHORMONE therapyThe emergence of resistance to prostate cancer (PCa) treatment, particularly to androgen deprivation therapy (ADT), has posed a significant challenge in the field of PCa management. Among the therapeutic options ...
In the realm of medical advancements, the treatment of prostate cancer, a significant health concern for middle-aged men, has seen remarkable progress. This article, tailored for students from elementary to high school, aims to educate you on the basics of prostate cancer, new therapies, and ho...
"The success of TULSA represents a revolution in whole-gland treatment forprostate cancer," said lead author Steven S. Raman, M.D., FASR, FSIR, professor of radiology, urology and surgery at the David Geffen School of Medicine at UCLA. "Prostate cancer is the most common form of cancer ...
Ad In this study, published in the journalFrontiers in Pharmacology, they propose a new treatment based on a combination of kinase inhibitors in patients who inevitably stop responding todocetaxel. The team found that resistance to this drug is associated with the hyperactivation of the cellular pat...
Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care James B. Yu, MD, MHS, FASTRO;Julian C. Hong, MD, MS July 1st 2024 Podcast AI tools may show utility in areas such as prostate diagnostic imaging, pathology, and treatment outcome predictions. FDA Accepts sNDA for Darolutamid...
Traditional Chinese medicine and pharmacy in the treatment of prostate cancer field is in the initial stage.It has great potential and prospects for development in improving the quality of life of patients,delaying tumor metastasis and progression.In this paper,traditional Chinese medicine treatment of...
Metastatic colorectal cancer (CRC) is still in need of effective treatments. This study applies a holistic approach to propose new targets for treatment of primary and liver metastatic CRC and investigates their therapeutic potential in-vitro. An integrative analysis of primary and metastatic CRC sampl...
Looking forward, studies focusing on things like PARP inhibition and treatment based on homologous recombination status have the potential to be practice-changing, according to Barata.Recent Videos Ga 68 PSMA-11 in Biology-Guided Radiotherapy for Prostate Cancer Han Discusses the Promise of Ga 68 ...
Genome-wide association studies (GWAS) have identified ~170 genetic loci associated with prostate cancer (PCa) risk, but most of them were identified in European populations. We here performed a GWAS and replication study using a large Japanese cohort (9
The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends. The largest comprehensive analysis reporting long-term risks from such treatment relative to the risks faced by